Vertex announces UK approval for CASGEVY™
Congratulations to Vertex for their UK approval for CASGEVY™, a CRISPR/Cas9 gene-edited therapy, for...
read Details
Incyte announces FDA approval for Zynyz™
Incyte announces FDA approval for Zynyz™
Congratulations to Incyte on their FDA approval for Zynyz™, a treatment for adults with metastatic or recurrent locally advanced Merkel cell carcinoma (MCC). Modality Solutions is proud to have been a part of its cold chain strategy!
Stay on top of the industry trends
You may also like
Melinta Therapeutics announces FDA approval of REZZAYO™
Congratulations to Melinta Therapeutics for their FDA Approval of REZZAYO™ for the Treatment of...
read Details
Iveric Bio announces FDA approval for IZERVAY™️️
Congratulations to Iveric Bio for their FDA approval for IZERVAY™️️, a new treatment for...
read Details